Lidolog Kit Recall Issued for Labeling Issue
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Asclemed USA Inc. is recalling 18 Lidolog Kits distributed in Tennessee due to a labeling defect where the wrap covers the barcode.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 11, 2026 and geographically references Tennessee. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Asclemed USA Inc. initiated a voluntary recall of Lidolog Kit because the label wrap covers the barcode, making it hard to scan.
Which Products Are Affected
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01. Lot: 070126X1, Exp. 12/31/2027. A total of 18 kits were distributed within Tennessee.
What You Should Do
No specific consumer action steps are provided in the recall notice.
Why This Matters
This is a Class III recall involving a labeling issue with no reported health risks.
Source
FDA recall number D-0713-2026, report date 20260729.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (713 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to August 11, 2026.
Frequently Asked Questions
Common questions about this FDA recall.